LDS/Medical Tests/Multiple Sclerosis Panel

Multiple Sclerosis Panel

Multiple sclerosis (MS) is a disease of the brain and spinal cord. MS is an autoimmune disorder that is characterized by the destruction of myelin, which affects nerve impulse conduction. Myelin is a protein-and- phospholipids-based molecule that makes up the protective sheath (myelin sheath) that surrounds and protects nerve fibers (axon) throughout the body. The myelin sheath also insulates the electrical impulses as they travel down the nerve fiber and allows the impulses to travel faster (up to 250 mph). Myelin is formed from the cell membrane from a type of cell called the Schwann cell. Myelin aids the rapid transmission of nerve impulses by preventing almost all electrical current leakage from the nerve fiber.

MS is an autoimmune disease that affects women more often than men. Diagnosis often occurs between age 20 and 40. Since nerves are affected by the disease, many areas of the body can be affected with various symptoms. Stress, sun exposure, hot baths, hot ambient temerpature, and fever can trigger symptoms. Some symptoms include: fatigue, loss of balance, muscle spasms, numbness, tingling, pain, coordination problems, weakness, double vision, vision loss, memory loss, slurred speech, and trouble chewing and swallowing.

Diagnosis of MS often occurs by performing a lumbar puncture (spinal tap) and performing testing on the CSF (Cerebrospinal Fluid). CSF is an important fluid that surrounds the brain and spinal cord. CSF is collected during a procedure called a lumbar puncture (spinal tap) into three to four clean sterile containers. It is important to know that white blood cell and red blood cell counts can be falsely elevated if the lumbar puncture causes bleeding into the puncture site (traumatic tap).

When aiding in the diagnosis of MS, many different tests can be used to determine if MS is the cause of the symptoms, which are not specific and could come from many different diseases. An MS panel usually includes cerebrospinal fluid analysis and findings as follow: 

  • Appearance: CSF is typically clear. A cloudy appearance may indicate the presence of cells or bacteria.
  • Color: CSF is typically colorless. Red or pink color may indicate the presence of blood and blood products. Straw, yellow, and amber (xanthochromia) pigments might indicate presence of bacterial and viral products due to infection and presence of WBC.
  • RBC: Normally no RBCs are seen in CSF. In cases of hemorrhage, stroke, and traumatic tap, RBC counts can greatly increase. The presence of red blood cells might indicate injury during the procedure. Clear distinctions must be made.
  • WBC: No WBC should be found in CSF. If present, WBC cell count and differentiation must be performed. Differentiation is usually expressed in percentage and includes: neutrophils, lymphocytes, monocytes/macrophage, eosinophils, and basophils. Increases in the number of white cells in CSF occur in meningitis caused by viral, bacterial, fungal, and parasitic infection. Increase in WBC in CSF also is seen in leukemia, multiple sclerosis, encephalitis, and Guillain-Barré syndrome as well as in brain injury or trauma. WBC count and differential is used to count and differentiate White Blood Cells present in the CSF. The number and type of WBCs seen within the CSF can help guide the diagnosis. For example, if most of the WBCs present are neutrophils, this will mostly indicate bacterial infection; if most cells present are lymphocytes, this would indicate viral infection; if eosinophils are present in analyzed CSF, it might be an indication of parasitic infection; and if basophils are mainly present, that might indicate multiple sclerosis.

Chemical components: Total proteins, Glucose, Urea Nitrogen and others.
Total proteins are usually present in very low amounts and are usually elevated in abnormal CSF, especially in multiple sclerosis and Guillain-Barré syndrome, infection, meningitis, and trauma.

Although increased total protein is common in multiple sclerosis and Guillain-Barré syndrome, it is not a conclusive indicator of the disease. Follow-up testing to determine the type of protein is necessary, along with other tests, to conclusively diagnose these conditions.

Protein Electrophoresis: Protein electrophoresis is a laboratory test used to evaluate proteins in various fluids in the body based on their electrical charge. The test is based on separation of serum proteins into albumin, α1, α2, β2, and γ fractions. Protein electrophoresis is used to identify patients with multiple sclerosis and central nervous tumors. In the case of MS, the protein subgroup called IgG will be elevated.

Myelin Basic Protein: This is an obsolete test in the diagnosis of MS, and is noted here for historical purposes. MBP is also increased in head injury, CNS trauma, tumor, stroke, and viral encephalitis. IgG Index: This is one of the two most important tests on CSF in the diagnosis of MS, the other being Oligoclonal Bands. Increased levels of IgG in patients with multiple sclerosis are seen in more than 75%.

Since this test compares cerebrospinal fluid IgG and albumin levels to serum IgG and albumin levels, this test is helpful in diagnosis of multiple sclerosis and other neural disorders associated with elevated levels of IgG. The IgG:albumin ratio is used to determine whether the IgG is being produced in the CSF or merely being transported across a more permeable blood-brain barrier. Unlike IgG, albumin is synthesized in the liver and it is not synthesized nor metabolized in the CSF compartment.

Oligoclonal Bands: This one of the two most important tests on CSF for the diagnosis of MS, the other being IgG index. The patients CSF is separated on a gel into bands using electrical charge and compared to a serum sample collected at the same time as the lumbar puncture. In MS, there will be four or more bands present in the CSF sample that are 1) typical of MS and 2) not present in the serum.

Cell Count:

  • Diagnosis of meningitis and encephalitis (viral, bacterial, fungal, or parasitic)
  • Diagnosis of metastatic tumors (e.g. leukemia) and central nervous system tumors
  • Diagnosis of syphilis
  • Diagnosis of hemorrhage in the brain and spinal cord
  • Diagnosis of multiple sclerosis
  • Diagnosis of Guillain-Barré syndrome

Total Protein- CSF:

  • Diagnosis of meningitis
  • Diagnosis of hemorrhage
  • Diagnosis of tumor
  • Diagnosis of multiple sclerosis
  • Diagnosis of Guillain-Barré syndrome

Protein Electrophoresis- CSF:

  • Diagnosis of multiple sclerosis
  • Diagnosis of central nervous tumors

Myelin Basic Protein:

  • No longer used in the diagnosis of multiple sclerosis

IgG Index:

  • As an aid in diagnosis of multiple sclerosis
  • As an aid in diagnosis of neurological disorders such as panencephalitis, neurosyphilis, and other CNS inflammatory diseases

Oligoclonal Bands:

  • As an aid in diagnosis of multiple sclerosis

WBC Count:

  • Increased in:
    • Infection (bacterial, viral, and parasitic)
    • Inflammation and trauma
    • Bleeding into the cerebrospinal fluid: abscess, encephalitis, hemorrhage, meningitis, multiple sclerosis, stroke, and tumor

RBC Count:

  • Increased in:
    • Bleeding
    • Traumatic tap 

Total Protein- CSF:

  • Increased in:
    • Bacterial Meningitis
    • Hemorrhage
    • Inflammatory diseases
    • Multiple sclerosis
    • Guillain-Barré syndrome

Protein Electrophoresis- CSF:

  • Increased in:
    • Central nervous tumors and cancers
    • Multiple sclerosis

Myelin Basic Protein:

  • Increased in:
    • Multiple sclerosis
    • Head injury
    • Central nervous system trauma
    • Tumor
    • Stroke
    • Viral encephalitis

IgG Index:

  • Increased in:
    • Multiple sclerosis (80 –90%)
    • Neurosyphilis
    • Subacute sclerosing panencephalitis, inflammatory and infectious CNS diseases

Oligoclonal Bands:

  • Increased in:
    • Multiple sclerosis: 4 or more bands that are CSF-unique, i.e., present in CSF but not in serum, is consistent with, but not specific for, MS.

Cell Count

Parameter Reference
Appearance Clear
Color Colorless
RBC None
WBC None
Neutrophils % Usually not seen; seen only in abnormal conditions
Lymphocytes % Usually not seen; seen only in abnormal conditions
Monocyte / Macrophage % Usually not seen; seen only in abnormal conditions
Eosinophils % Usually not seen; seen only in abnormal conditions

 

Total Protein – CSF

Analyte Reference Range
Total Protein 0–35 mg/dL

 

Protein Electrophoresis – CSF

Fraction % of Total Protein
Prealbumin 2.2–7.1%
Albumin 56.8–76.4%
Alpha-1 globulin 1.1–6.6%
Beta globulin 7.3–17.9%
Gamma globulin 3.0–13.0%

 

Myelin Basic Protein

µg/L Interpretation
0–4.0 Negative
4.1–6.0 Weakly Positive
>6.0 Positive

 

IgG Index

Parameter Reference
CSF IgG Index <0.7 (IgGCSF/AlbuminCSF) / (IgGSerum/AlbuminSerum)
CSF IgG : Albumin Ratio <0.27 (IgGCSF : AlbuminCSF)
CSF : Serum Albumin Ratio <9 is consistent with an intact barrier (AlbuminCSF / AlbuminSerum)
**Cell Count:** Microscopic Visual Examination **Total Protein-CSF:** Photometric, Turbidimetric **Protein Electrophoresis-CSF:** Electrophoresis** on agarose media (gel), capillary electrophoresis **Myelin Basic Protein:** Immunoassay **IgG Index:** Radial Immunodiffusion, Electroimmunodiffusion, Immunofluorometry, Immunoprecipitation, Immunonephelometry, Rate Immunonephelometry **Oligoclonal Bands:** Isoelectric Focusing followed by SDS/PAGE gel electrophoresis IgGy

Cerebrospinal fluid (CSF) collected in a sterile tube, Serum (SST).  

  • Cell Count: 1mL Cerebral Spinal Fluid (preferably tube 3 of 4 tubes collected)
  • Total Protein- CSF: 1 mL CSF (tube 1 of 4 tubes collected)
  • Protein Electrophoresis- CSF: 1 mL CSF (tube 1 or 4 of 4 tubes collected)
  • Myelin Basic Protein: 1.2 mL CSF (tube 1 or 4 of 4 tubes)
  • IgG Index: Preferably 3mL of CSF and one serum sample.(Tube 4)

Stability

  • Ambient: 8 hours
    Refrigerated: 5-7 days 
    Frozen: 30 days
CSF analysis, CSF Gram stain and culture, viral culture, yeast culture, Complete Blood Cell Count, serum proteins, serum protein electrophoresis, bone marrow analysis.

1-3 days. 

Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • AdvClin Chem. 2006;42:43. [PMID: 17131624]
  • Am Fam Physician. 2005 Jan 1;71(1):105-12. [PMID: 15663032]
  • ClinChem Lab Med. 2003 Jun;41(6):762-72. [PMID: 12880139]
  • MultScler. 2009 Dec;15(12):1466-80. [PMID: 19995844]
  • ClinNeuropharmacol. 2003 Jan-Feb;26(1):28-37. [PMID: 12567162]
  • J Neuroimmunol. 2002;125:149. [PMID: 11960651]
  • J Neurol Sci. 2003;216:61. [PMID: 14607304]
  • Jacobs DS, DeMott WR. Laboratory Test Handbook. Hudson, OH. Lexi-Comp, Inc (2001).
  • Tietz NW. Textbook of Clinical Chemistry. Philadelphia. W.B. Saunders Company (1986).
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757